• Return to Headlines

Myriad Genetics Up 37.1% Since SmarTrend Uptrend Call (MYGN)

By David Diaz

SmarTrend identified an Uptrend for Myriad Genetics (NASDAQ:MYGN) on May 8th, 2018 at $31.65. In approximately 3 months, Myriad Genetics has returned 37.08% as of today's recent price of $43.38.

In the past 52 weeks, shares of Myriad Genetics have traded between a low of $15.15 and a high of $44.87 and are now at $43.38, which is 186% above that low price. The 200-day and 50-day moving averages have moved 0.53% higher and 1.43% higher over the past week, respectively.

Myriad Genetics, Inc. develops and markets molecular diagnostic products to provide physicians with information to help guide the care of their patients, to prevent disease, delay the onset of disease, or catch disease at an early stage.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Myriad Genetics shares.

Log in and add Myriad Genetics (MYGN) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights myriad genetics

Ticker(s): MYGN